As of April 1, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) trades at $13.68, marking a 0.51% decline in the latest trading session. This analysis explores key technical levels, recent market context for the biopharmaceutical stock, and potential near-term price scenarios based on current trading patterns. No recent earnings data is available for TNXP as of this writing, so price action is currently driven primarily by sector sentiment and technical flows rather than quarterly fundamental pe
TNXP Stock Analysis: Tonix Pharmaceuticals Holding Corp dips 0.51 pct to 13.68
TNXP - Stock Analysis
4063 Comments
1844 Likes
1
Mariana
Legendary User
2 hours ago
I know there are others thinking this.
👍 93
Reply
2
Christianjohn
Returning User
5 hours ago
Let’s find the others who noticed.
👍 79
Reply
3
Hursel
Expert Member
1 day ago
Everyone should take notes from this. 📝
👍 293
Reply
4
Nimsy
Trusted Reader
1 day ago
This feels like knowledge I shouldn’t have.
👍 59
Reply
5
Layklyn
Active Contributor
2 days ago
Market breadth indicates healthy participation from retail investors.
👍 119
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.